The Associated Press reports:
Vaccine makers are racing to update their COVID-19 shots against the newest coronavirus threat even before it’s clear a change is needed, just in case.
Experts doubt today’s shots will become useless but say it’s critical to see how fast companies could produce a reformulated dose and prove it works — because whatever happens with omicron, this newest mutant won’t be the last.
Pfizer expects to have an omicron-specific candidate ready for the Food and Drug Administration to consider in March.
Read the full article.
Pfizer and Moderna have practiced tweaking their shots against earlier mutants so they’d know how to do so, but making new doses still would take months. https://t.co/5xYTrSUOnO
— KSDK News (@ksdknews) December 9, 2021